Arthritis and Osteoporosis Consultants of the Carolinas | Midtown Medical Plaza

Research site

(Unclaimed)

Location

1918 Randolph Road Suite 600, Charlotte, North Carolina, United States of America

Site insights

Top conditions

Top treatments

Dazodalibep

Belimumab

Deucravacitinib

Naproxen

Celecoxib

Ixekizumab

RSLV-132

Tanezumab

Obinutuzumab

Baricitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 18 total trials

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

The primary objective of this trial is to evaluate the effect of pegloticase 18 mg subcutaneously (SC) every two weeks with methotrexate (MTX) versus...

Enrolling

Uncontrolled Gout

Drug: Pegloticase

Drug: Methotrexate

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

Primary Objective:To evaluate the effect of dazodalibep on patient-reported symptoms of SS in participants with moderate-to-severe symptom stateSecon...

Active, not recruiting

Sjögren's Syndrome (SS)

Drug: Dazodalibep

Drug: Placebo

A Study of RSLV-132 in Females With Sjögren's Disease

The goal of this clinical study is to learn if RSLV-132 improves the symptoms of SS in adults. It will also learn about the safety of RSLV-132. The m...

Enrolling

Primary Sjögren Syndrome

Drug: RSLV-132

Drug: Placebo

A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-1)

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe System...

Active, not recruiting

Systemic Lupus Erythematosus

Other: Placebo

Drug: Deucravacitinib

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease (UPSTREAM SjD)

Enrolling

Primary Sjogren's Disease

Biological: Telitacicept

Drug: Placebo

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

The goal of this clinical study is to assess the efficacy and safety of LUPKYNIS® in combination with belimumab, obinutuzumab or anifrolumab at induc...

Enrolling

Lupus Nephritis

Drug: mycophenolic acid analog (MPAA)

Drug: LUPKYNIS

Locations recently updated

Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica

This is a randomized, double-blind, placebo-controlled, parallel-group, Phase 4, 3-group study to assess whether treatment with sarilumab at either 1...

Enrolling

Polymyalgia Rheumatica

Drug: Placebo

Drug: Sarilumab